Buckets:
| { | |
| "model": "Base_t0.95", | |
| "n_sequences_annotated": 3147, | |
| "total_hits": 22764, | |
| "by_type": { | |
| "CDS": 7711, | |
| "promoter": 4281, | |
| "rep_origin": 2980, | |
| "terminator": 2875, | |
| "misc_feature": 1410, | |
| "protein_bind": 1276, | |
| "enhancer": 605, | |
| "polyA_signal": 385, | |
| "misc_RNA": 336, | |
| "ncRNA": 245, | |
| "LTR": 202, | |
| "RBS": 169, | |
| "intron": 137, | |
| "mobile_element": 43, | |
| "gene": 36, | |
| "repeat_region": 34, | |
| "oriT": 23, | |
| "sig_peptide": 8, | |
| "misc_recomb": 4, | |
| "3'UTR": 2, | |
| "5'UTR": 2 | |
| }, | |
| "by_type_and_description": [ | |
| { | |
| "type": "rep_origin", | |
| "description": "high-copy-number ColE1/pMB1/pBR322/pUC origin of replication", | |
| "count": 1537 | |
| }, | |
| { | |
| "type": "terminator", | |
| "description": "transcription terminator T1 from the E. coli rrnB gene", | |
| "count": 1020 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "bla", | |
| "count": 815 | |
| }, | |
| { | |
| "type": "terminator", | |
| "description": "phage T7 early transcription terminator", | |
| "count": 803 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "\u03b2-lactamase; bla; confers resistance to ampicillin, carbenicillin, and related antibiotics", | |
| "count": 679 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "aminoglycoside phosphotransferase; aph(3')-Ia; confers resistance to kanamycin in bacteria or G418 (Geneticin\u00ae) in eukaryotes", | |
| "count": 645 | |
| }, | |
| { | |
| "type": "enhancer", | |
| "description": "human cytomegalovirus immediate early enhancer", | |
| "count": 581 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "lac repressor; lacI; The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-\u03b2-D-thiogalactopyranoside (IPTG).", | |
| "count": 573 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "bacterial promoter (Registry of Standard Biological Parts BBa J23119)", | |
| "count": 573 | |
| }, | |
| { | |
| "type": "rep_origin", | |
| "description": "Plasmids containing the medium-copy-number p15A origin of replication can be propagated in E. coli cells that contain a second plasmid with the ColE1 origin.", | |
| "count": 536 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "hfriFP is a fluorescent protein published in 2013, derived from Herbaspirillum frisingense.", | |
| "count": 515 | |
| }, | |
| { | |
| "type": "protein_bind", | |
| "description": "The lac repressor binds to the lac operator to inhibit transcription in E. coli. This inhibition can be relieved by adding lactose or isopropyl-\u03b2-D-thiogalactopyranoside (IPTG). lac repressor encoded by lacI", | |
| "count": 472 | |
| }, | |
| { | |
| "type": "protein_bind", | |
| "description": "CAP binding activates transcription in the presence of cAMP. E. coli catabolite activator protein", | |
| "count": 437 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "promoter for bacteriophage T7 RNA polymerase", | |
| "count": 432 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "basis of mobility region from pBR322", | |
| "count": 412 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "bacterial promoter (Registry of Standard Biological Parts BBa J23119) modified to end with an SpeI site", | |
| "count": 380 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "monomeric derivative of DsRed (Campbell et al., 2002)", | |
| "count": 376 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "tetracycline efflux protein; tet; confers resistance to tetracycline", | |
| "count": 347 | |
| }, | |
| { | |
| "type": "rep_origin", | |
| "description": "f1 bacteriophage origin of replication; arrow indicates direction of (+) strand synthesis", | |
| "count": 327 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "Rop protein, which maintains plasmids at low copy number; rop", | |
| "count": 317 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "LacZ\u03b1 fragment of \u03b2-galactosidase; lacZ fragment", | |
| "count": 314 | |
| }, | |
| { | |
| "type": "terminator", | |
| "description": "transcription terminator from phage lambda", | |
| "count": 314 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "promoter for the E. coli lac operon", | |
| "count": 299 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "composite tag for in vivo biotinylation, TEV protease cleavage, and 6xHis tagging", | |
| "count": 292 | |
| }, | |
| { | |
| "type": "misc_RNA", | |
| "description": "guide RNA scaffold for the Streptococcus pyogenes CRISPR/Cas9 system", | |
| "count": 286 | |
| }, | |
| { | |
| "type": "ncRNA", | |
| "description": "Accession: RF00001 - 5S ribosomal RNA", | |
| "count": 232 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "replication protein for the broad-host-range plasmid pBBR1 from Bordetella bronchiseptica", | |
| "count": 220 | |
| }, | |
| { | |
| "type": "rep_origin", | |
| "description": "replication origin of the broad-host-range plasmid pBBR1 from Bordetella bronchiseptica; requires the pBBR1 Rep protein for replication", | |
| "count": 219 | |
| }, | |
| { | |
| "type": "terminator", | |
| "description": "transcription terminator for bacteriophage T7 RNA polymerase", | |
| "count": 197 | |
| }, | |
| { | |
| "type": "polyA_signal", | |
| "description": "SV40 polyadenylation signal", | |
| "count": 182 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "promoter of the E. coli cat gene encoding chloramphenicol acetyltransferase", | |
| "count": 169 | |
| }, | |
| { | |
| "type": "RBS", | |
| "description": "efficient ribosome binding site from bacteriophage T7 gene 10 (Olins and Rangwala, 1989)", | |
| "count": 169 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "solubility-enhancement tag derived from T7 phage gene 10B", | |
| "count": 164 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "pBluescript multiple cloning site", | |
| "count": 142 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "pUC18/19 multiple cloning site", | |
| "count": 138 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "Protein predicted: Swiss-Prot protein existence level 4. From Escherichia coli.", | |
| "count": 133 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "promoter for bacteriophage T3 RNA polymerase", | |
| "count": 127 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "central polypurine tract and central termination sequence of HIV-1", | |
| "count": 123 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "SV40 enhancer and early promoter", | |
| "count": 119 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "lacI", | |
| "count": 118 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "CAT_ECOLX - Experimental evidence at protein level: Swiss-Prot protein existence level 1. This enzyme is an effector of chloramphenicol resistance in bacteria. From Escherichia coli. This protein is used as a marker in many commonly used cloning vectors, such as pACYC184.", | |
| "count": 113 | |
| }, | |
| { | |
| "type": "terminator", | |
| "description": "Escherichia coli rrnB; transcription terminator T1 from the E. coli rrnB gene", | |
| "count": 109 | |
| }, | |
| { | |
| "type": "LTR", | |
| "description": "truncated 5' long terminal repeat (LTR) from HIV-1", | |
| "count": 106 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "9xHis affinity tag", | |
| "count": 94 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "woodchuck hepatitis virus posttranscriptional regulatory element", | |
| "count": 89 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "promoter for bacteriophage SP6 RNA polymerase", | |
| "count": 86 | |
| }, | |
| { | |
| "type": "protein_bind", | |
| "description": "mutant version of attB; recombination site for the Gateway\u00ae BP reaction BP Clonase\u2122", | |
| "count": 85 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "E. coli promoter for tetracycline efflux protein gene", | |
| "count": 85 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "human cytomegalovirus (CMV) immediate early promoter", | |
| "count": 84 | |
| }, | |
| { | |
| "type": "polyA_signal", | |
| "description": "bovine growth hormone polyadenylation signal", | |
| "count": 83 | |
| }, | |
| { | |
| "type": "protein_bind", | |
| "description": "mutant version of attL; recombination site for the Gateway\u00ae LR reaction LR Clonase\u2122", | |
| "count": 81 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "large T antigen from SV40 (simian virus 40)", | |
| "count": 80 | |
| }, | |
| { | |
| "type": "promoter", | |
| "description": "RNA polymerase III promoter for human U6 snRNA", | |
| "count": 79 | |
| }, | |
| { | |
| "type": "rep_origin", | |
| "description": "SV40 origin of replication", | |
| "count": 78 | |
| }, | |
| { | |
| "type": "rep_origin", | |
| "description": "Plasmids containing the RSF 1030 origin of replication can be propagated in E. coli cells that contain additional plasmids with compatible origins.", | |
| "count": 78 | |
| }, | |
| { | |
| "type": "terminator", | |
| "description": "transcription terminator T2 from the E. coli rrnB gene", | |
| "count": 75 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "TN5P_ECOLX - Also known as tnp. Experimental evidence at protein level: Swiss-Prot protein existence level 1. Mediates transposition of transposon Tn5 by a 'cut and paste' mechanism. First, the monomeric transposase binds the 19 bp inverted DNA repeats flanking the transposon. Then, dimerization of the DNA- bound transposase creates a synaptic DNA complex. After nicking of the first DNA strand, excision of the transposon proceeds through a series of intermediates. The transposase then mediates the insertion of the transposon at a new site by strand transfer. The activity of the wild- type transposase is very low, and is further inhibited by dimerization with the transposase inhibitor (inh). From Escherichia coli.", | |
| "count": 73 | |
| }, | |
| { | |
| "type": "CDS", | |
| "description": "chloramphenicol acetyltransferase; cat; confers resistance to chloramphenicol", | |
| "count": 67 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "The Rev response element (RRE) of HIV-1 allows for Rev-dependent mRNA export from the nucleus to the cytoplasm.", | |
| "count": 66 | |
| }, | |
| { | |
| "type": "misc_feature", | |
| "description": "universal suffix for all parts", | |
| "count": 65 | |
| } | |
| ] | |
| } |
Xet Storage Details
- Size:
- 10.5 kB
- Xet hash:
- 0c2fd248917832f159333735a9a6de8266345c86b36951b1653d1c82793fb6f8
·
Xet efficiently stores files, intelligently splitting them into unique chunks and accelerating uploads and downloads. More info.